These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 10416484)
21. The quality of reporting of orthopaedic randomized trials with use of a checklist for nonpharmacological therapies. Chan S; Bhandari M J Bone Joint Surg Am; 2007 Sep; 89(9):1970-8. PubMed ID: 17768194 [TBL] [Abstract][Full Text] [Related]
23. Explanations for improvement in both experimental and control groups. Becker H; Roberts G; Voelmeck W West J Nurs Res; 2003 Oct; 25(6):746-55. PubMed ID: 14528620 [TBL] [Abstract][Full Text] [Related]
24. An analysis of protocols and publications suggested that most discontinuations of clinical trials were not based on preplanned interim analyses or stopping rules. Stegert M; Kasenda B; von Elm E; You JJ; Blümle A; Tomonaga Y; Saccilotto R; Amstutz A; Bengough T; Briel M; J Clin Epidemiol; 2016 Jan; 69():152-60. PubMed ID: 26361993 [TBL] [Abstract][Full Text] [Related]
25. A decision-theoretic evaluation of early stopping rules. Heitjan DF; Houts PS; Harvey HA Stat Med; 1992 Mar; 11(5):673-83. PubMed ID: 1594809 [TBL] [Abstract][Full Text] [Related]
26. [Roaming through methodology. XXIV. Problems in generalizing from randomized intervention studies with selected patient populations]. Zielhuis GA Ned Tijdschr Geneeskd; 2000 Sep; 144(39):1860-4. PubMed ID: 11031678 [TBL] [Abstract][Full Text] [Related]
27. Clinical trials in the new millennium. DeMets DL Stat Med; 2002 Oct; 21(19):2779-87. PubMed ID: 12325093 [TBL] [Abstract][Full Text] [Related]
28. [Variation and inconsistency in the evaluation of experiments by medical ethics committees]. Bergkamp L Ned Tijdschr Geneeskd; 1989 Mar; 133(9):446-9. PubMed ID: 2710252 [TBL] [Abstract][Full Text] [Related]
29. Assessment of risk of bias in randomized clinical trials in surgery. Gurusamy KS; Gluud C; Nikolova D; Davidson BR Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747 [TBL] [Abstract][Full Text] [Related]
30. Early stopping rules in oncology: considerations for clinicians. Mukherjee SD; Goffin JR; Taylor V; Anderson KK; Pond GR Eur J Cancer; 2011 Nov; 47(16):2381-6. PubMed ID: 21684153 [TBL] [Abstract][Full Text] [Related]
31. When an interim analysis of randomized trial changes the practice in oncology: The lesson of adjuvant trastuzumab and the HERA trial. De Rossi C; Brunello A; Jirillo G; Jirillo A Immunopharmacol Immunotoxicol; 2009; 31(1):1-4. PubMed ID: 19238693 [TBL] [Abstract][Full Text] [Related]
33. Early stopping rules and long-term follow-up in phase III trials. Pignon JP; Arriagada R Lung Cancer; 1994 Mar; 10 Suppl 1():S151-9. PubMed ID: 8087505 [TBL] [Abstract][Full Text] [Related]
34. Basics of designing a clinical trial: part I. Whitney JD J Wound Ostomy Continence Nurs; 2000 Sep; 27(5):257-9. PubMed ID: 10999963 [No Abstract] [Full Text] [Related]
35. Randomized trials and placebo. Blair KC Adv Mind Body Med; 2003; 19(1):4; author reply 4-5. PubMed ID: 12825407 [No Abstract] [Full Text] [Related]
36. Redefining the randomized controlled trial in the context of acupuncture research. Walji R; Boon H Complement Ther Clin Pract; 2006 May; 12(2):91-6. PubMed ID: 16648085 [TBL] [Abstract][Full Text] [Related]
37. Reporting on data monitoring committees in neonatal randomised controlled trials is inconsistent. Perrem LM; Gosling S; Ravikumar I; Khashan AS; Miletin J; Ryan CA; Dempsey E Acta Paediatr; 2017 Jan; 106(1):30-33. PubMed ID: 27637413 [TBL] [Abstract][Full Text] [Related]
38. Frequentist evaluation of group sequential clinical trial designs. Emerson SS; Kittelson JM; Gillen DL Stat Med; 2007 Dec; 26(28):5047-80. PubMed ID: 17573678 [TBL] [Abstract][Full Text] [Related]
39. Poor statistical design in research on humans: the role of committees on human research. Giammona M; Glantz SA Clin Res; 1983 Dec; 31(5):572-8. PubMed ID: 6667598 [No Abstract] [Full Text] [Related]